Testing the effect of the diabetes drug Liraglutide in Alzheimer's disease
Research Project: Evaluating the effects of the novel GLP-1 analogue, Liraglutide, in patients with Alzheimer's disease (ELAD) study
You searched for 'liraglutide':
Showing 1-10 of about 13
Diabetes drug shows promise
From ,Care and cure magazine - Autumn 2015 read about a diabetes drug (liraglutide) that was tested for dementia treatments.
Study finds diabetes medication may help alleviate Alzheimer's disease - Alzheimer's Society comments
Research published today in PLOS One online suggests that diabetes drugs could reduce the markers of Alzheimer's disease.
Drug Discovery
An exciting new approach to developing treatments for dementia by 'repurposing' existing drugs.
An ideal match - scientists finding research volunteers
From the spring 2015 issue of our Care and Cure research magazine, find out more about how scientists are being matched with volunteers to help on their research projects.
Testing type-2 diabetes drugs as potential treatments for Alzheimer's disease
Read about a research project we funded: Novel GLP-1 and GIP dual receptor agonist peptides show neuroprotective effects.
New research shows promise for Phase 2/3 trial of inhaled insulin in people with MCI or mid Alzheimer’s disease – Alzheimer’s Society comment
Phase 2/3 clinical trial results shows early promise for an inhaled insulin spray in people with mild cognitive impairment (MCI) or mild Alzheimer’s disease.
The view looking in
From the spring 2015 edition of Care and Cure research magazine, find out about how researchers can scan brains for signs of Alzheimer's disease.
Diabetes link discovered
Find out about brain changes which reveal a mechanism that could link diabetes and dementia.
Our research impact
Alzheimer's Society funds cutting-edge research into the cause, care, cure and prevention of dementia. Here are some of our important highlights.